RESOURCE LINKS

DRUG ALERTS & UPDATES

PROVIDER TOOLS

Providers:  We’re here to help

Our partnership with our members’ healthcare providers is essential to ensure that we continue to deliver best in class pharmacy care to our members. We work closely with providers to deliver appropriate care management designed to lower net costs while maximizing health outcomes. The overall result: happier and healthier patients!

Member Services: 1.877.241.7123 / TDD 1.888.907.0020

Pharmacy Help Desk Assistance: 1.888.907.0050

Prior Auths/DUR: 1.888.723.6001

NEWS RELEASES

FDA has approved Epclusa – New treatment for Chronic Hepatitis C

On June 28, 2016, FDA approved Gilead’s new drug, Epclusa, to treat adult patients with chronic hepatitis C virus (HCV) both with and without cirrhosis (advanced liver disease). For patients with moderate to severe cirrhosis (decompensated cirrhosis), Epclusa is approved for use in combination with the drug ribavirin.

read more

PCSK9 Inhibitors

What are PCSK9 Inhibitors? The Food and Drug Administration recently approved two products in a new class of cholesterol-lowering drugs known as PCSK9 Inhibitors. This class of drugs reduces the amount of low-density lipoprotein cholesterol (LDL-C), or “bad... read more

HEALTHCARE NEWS